Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | |||
neurolists:cae_and_jae [2024/03/09 20:43] – biju.hameed@gmail.com | neurolists:cae_and_jae [2024/03/09 20:43] (current) – biju.hameed@gmail.com | ||
---|---|---|---|
Line 2: | Line 2: | ||
* Age at onset of CAE is considered to be 2 to 13 years of age and for Juvenile Absence Epilepsy (JAE) to be 8 to 20 years of age; there is five years of overlap[(: | * Age at onset of CAE is considered to be 2 to 13 years of age and for Juvenile Absence Epilepsy (JAE) to be 8 to 20 years of age; there is five years of overlap[(: | ||
* Patients with JAE more often have GTCS and more frequently experience seizure-related injuries compared with patients with CAE | * Patients with JAE more often have GTCS and more frequently experience seizure-related injuries compared with patients with CAE | ||
- | * Valproate can be considered as the drug of choice in men and lamotrigine as the first drug of choice in women with JAE. See | + | * Valproate can be considered as the drug of choice in men and lamotrigine as the first drug of choice in women with JAE. |
* CAE has a good prognosis (most patients will become seizure-free off ASMs[(: | * CAE has a good prognosis (most patients will become seizure-free off ASMs[(: | ||
< | < |